Page last updated: 2024-08-24

cephalosporin c and ly 163892

cephalosporin c has been researched along with ly 163892 in 103 studies

Research

Studies (103)

Timeframe	Studies, this research(%)	All Research%
pre-1990	13 (12.62)	18.7374
1990's	81 (78.64)	18.2507
2000's	6 (5.83)	29.6817
2010's	3 (2.91)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Jacobs, NF; Moellering, RC	1
Burman, LG; Kallings, I; Olsson-Liljequist, B	1
Fah, YS; Powell, M; Seymour, A; Williams, JD; Yuan, M	1
Boeckh, M; Deppermann, KM; Koeppe, P; Lode, H; Roller, S; Stelzer, I	1
Barry, AL; Doern, GV; Ferraro, MJ; Jorgensen, JH; Murray, PR	1
Dolence, EK; McKee, JA; Miller, MJ; Minnick, AA	1
Gwaltney, J; Huck, W; Nielsen, RW; Scheld, WM; Sydnor, TA; Therasse, DG	1
Foshee, WS; Qvarnberg, Y	1
Disney, FA; Hanfling, MJ; Hausinger, SA	1
Hanfling, MJ; Hausinger, SA; Squires, J	1
Indelicato, JM; Pasini, CE	1
Foshee, WS	1
Syrop, J	1
DeSante, KA; Zeckel, ML	1
Copper, RD	1
Therasse, DG	1
Dere, WH	1
Zeckel, ML	1
Hyslop, DL	1
Doern, G	1
Nielsen, RW	1
McCarty, J	1
Jacobson, KD; McCarty, J; Ruoff, GE	1
Bischoff, W; Hyslop, DL	1
Bischoff, W; Iravani, A	1
Van der Auwera, P	1
Brumfitt, W; Hamilton-Miller, JM	1
Eckernäs, SA; Grahnen, A; Nord, CE	1
Gan, VN; Kusmiesz, H; Nelson, JD; Shelton, S	1
Akaniro, JC; Arguedas, AG; Arrieta, AC; Marks, MI; Stutman, HR	1
Brier, G; Kovach, PM; Lantz, RJ	1
Doern, GV; Parker, D; Torres, B; Tubert, T; Vautour, R	1
Iravani, A	1
Adinolfi, LE; Marrone, A; Ruggiero, G; Tripodi, MF; Utili, R	1
Brown, O; Kusmiesz, H; Manning, S; Nelson, JD; Shelton, S	1
Hirata, T; Matsukuma, I; Mochida, K; Okachi, R; Sato, K	1
Dunkin, KT; Howard, AJ	1
Nelson, JD; Shelton, S	1
Gratton, CA; Kibsey, PC; Knight, VE; Wenman, WM	1
Fontana, R; Pelosi, E	1
Barry, AL; Jones, RN	3
Jorgensen, JH; Maher, LA; Redding, JS	1
Kusmiesz, H; Nelson, JD; Shelton, S	1
Cao, C; Chin, NX; Neu, HC	1
Knapp, CC; Washington, JA	1
Baertschi, SW; Collins, MW; Dorman, DE; Lorenz, LJ; Spangle, LA	1
Brogden, RN; McTavish, D	1
Anderson, RL; McKnight, JT; Rodman, DP	1
Chen, J; Dantzig, AH; Hu, M; Kuhfeld, MT; Stratford, RE; Zhu, Y	1
Doern, GV; Gerlach, EH; Hindler, J; Jones, RN; St Amand, R	1
Aoki, FY; Hoban, DJ; Sitar, DS	1
Beumer, H; Floor, M; Kolsters, A; Rozenberg-Arska, M; van Akkeren, F; Verhoef, J; Visser, M	1
Rodriguez, WJ; Wiedermann, BL	1
Andrews, JM; Lees, AS; Wise, R	1
Biedenbach, DJ; Jones, RN	1
Dantzig, AH; Duckworth, DC; Tabas, LB	1
Bilton, D; Hill, SL; Johnson, MM; Mitchell, JL; Pye, A; Stockley, RA	1
Bass, JW; Chan, DS; Demers, DM	1
Baertschi, SW; Collins, MW; Dorman, DE; Lorenz, LJ; Occolowitz, JL; Paschal, JW; Skibic, MJ; Spangle, LA; Taylor, KW	1
Belcher, J; Cole, PJ; Kanthakumar, K; Lund, V; Read, RC; Roberts, DE; Rutman, A; Tsang, KW; Wilson, R	1
Greenfield, RA	1
Cerimele, BJ; Davidson, RL; DeSante, KA; Farlow, DS; Hatcher, BL; Quadracci, LJ; Therasse, DG	1
Berman, S; Roark, R	1
Hussar, DA	1
Bendele, A; Buening, M; Clemens, J; Colbert, W; Deldar, A; Helton, D; McGrath, J; Shannon, H; Shetler, T; Turk, J	1
Force, RW; Nahata, MC	1
Kamme, C; Petersson, AC	1
Borner, K; Fassbender, M; Koeppe, P; Lode, H; Schaberg, T	1
Aspinall, S; Connell, C; Corkill, J	1
Caldwell, SA; Lum, GM; Thieme, RE	1
Fravert, D; Hsu, CY; Tune, BM	1
Daniel, H; Thwaites, DT; Wenzel, U	1
Cappelletty, DM; Rybak, MJ	1
Chen, J; Dantzig, AH; Hu, M; Stratford, RE; Zheng, L	1
Chen, J; Dantzig, AH; Hu, M; Li, Y; Liu, L; Stratford, RE; Zheng, L	1
Itokazu, GS; Karavokiros, KT; Schatz, BS; Taeubel, MA	1
Gonzales, J; Overturf, GD; Shandler, L	1
Björnsson, E; Olsson, R	1
Benn, RA; Fernandes, CJ; Nimmo, GR	1
Larsson, P; Roos, K	1
Berry, DM; Dantzig, AH; Duckworth, DC; Snyder, NJ; Spry, DO; Tabas, LB	1
Preston, DA; Turik, M	1
Gould, IM; Mackenzie, FM; Milne, KE	1
Abdel-Rahman, SM; Blowey, DL; Kauffmann, RE; Kearns, GL	1
Blondeau, JM; Borsos, S; Suter, M	1
Adelglass, J; Gooch, WM; Johns, D; Kelsey, DK; Masica, D; Weinberg, BC	1
Allen, BS; Bandak, SI; Bolzon, LD; Preston, DA; Turnak, MR	1
Griffin, TJ; Keyserling, CH; McAdoo, MA; Nemeth, MA; Paster, RZ; Tack, KJ	1
Kalich, S; Nilsson-Ehle, I; Nord, CE; Ochs, HR; Odenholt, I; Vogel, F; Wettich, K	1
Arghittu, M; Colombo, R; Conio, F; Gagliardi, L; Garlaschi, ML; Rusconi, F; Sala, A; Sideri, S; Varotto, F	1
Aljitawi, OS; Aster, RH; Bougie, DW; Curtis, BR; Krishnan, K	1
Kamme, C; Orrling, A; Stjernquist-Desatnik, A	1
Heidron, F; Knothe, H; Sammann, A; Schäfer, V	1
Balatsouras, DG; Eliopoulos, P; Ferekidis, E; Korres, S; Rallis, E	1
Correra, TC; Hu, CQ; Li, J; Maître, P; Qian, JQ; Song, DQ	1
Amicosante, G; Bottoni, C; Celenza, G; Colapietro, M; Galleni, M; Kerff, F; Marcoccia, F; Matagne, A; Mercuri, PS; Perilli, M; Sabatini, A	1
Cattrall, JWS; Kirby, A; Robinson, AV	1

Reviews

18 review(s) available for cephalosporin c and ly 163892

Article	Year
Comparative United States and European trials of loracarbef in the treatment of acute otitis media. The Pediatric infectious disease journal, 1992, Volume: 11, Issue:8 Suppl Topics: Acute Disease; Amoxicillin; Cephalosporins; Clinical Trials as Topic; Europe; Humans; Otitis Media; United States	1992
Pharmacokinetic profile of loracarbef. The American journal of medicine, 1992, Jun-22, Volume: 92, Issue:6A Topics: Adult; Age Factors; Biological Availability; Cephalosporins; Child; Clinical Trials as Topic; Food; Humans; Kidney Diseases; Metabolic Clearance Rate; Probenecid	1992
The carbacephems: a new beta-lactam antibiotic class. The American journal of medicine, 1992, Jun-22, Volume: 92, Issue:6A Topics: Ambulatory Care; Animals; Anti-Bacterial Agents; Biological Availability; Cephalosporins; Clinical Trials as Topic; Dogs; Drug Evaluation, Preclinical; Drug Stability; Esters; Haplorhini; Humans; Mice; Microbial Sensitivity Tests	1992
The safety profile of loracarbef: clinical trials in respiratory, skin, and urinary tract infections. The American journal of medicine, 1992, Jun-22, Volume: 92, Issue:6A Topics: Adult; Adverse Drug Reaction Reporting Systems; Aged; Cephalosporins; Child; Diarrhea; Headache; Humans; Incidence; Intestines; Respiratory Tract Infections; Skin Diseases, Infectious; Urinary Tract Infections	1992
Acute bronchitis: results of U.S. and European trials of antibiotic therapy. The American journal of medicine, 1992, Jun-22, Volume: 92, Issue:6A Topics: Acute Disease; Bronchitis; Cephalosporins; Clinical Trials as Topic; Drug Resistance, Microbial; Europe; Gastrointestinal Diseases; Humans; Respiratory Tract Infections; United States	1992
Loracarbef (LY163892) in the treatment of acute exacerbations of chronic bronchitis: results of U.S. and European comparative clinical trials. The American journal of medicine, 1992, Jun-22, Volume: 92, Issue:6A Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Bronchitis; Cephalosporins; Chronic Disease; Clavulanic Acids; Diarrhea; Drug Therapy, Combination; Europe; Female; Headache; Humans; Incidence; Male; Middle Aged; Treatment Outcome; United States	1992
Efficacy and safety of loracarbef in the treatment of pneumonia. The American journal of medicine, 1992, Jun-22, Volume: 92, Issue:6A Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Bacterial Infections; Cephalosporins; Clavulanic Acids; Drug Therapy, Combination; Humans; Nausea; Pneumonia; Randomized Controlled Trials as Topic; Vomiting	1992
In vitro activity of loracarbef and effects of susceptibility test methods. The American journal of medicine, 1992, Jun-22, Volume: 92, Issue:6A Topics: Cephalosporins; Clinical Protocols; Clinical Trials as Topic; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Treatment Outcome	1992
Acute bacterial maxillary sinusitis: results of U.S. and European comparative therapy trials. The American journal of medicine, 1992, Jun-22, Volume: 92, Issue:6A Topics: Adolescent; Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Cephalosporins; Clavulanic Acids; Double-Blind Method; Doxycycline; Drug Therapy, Combination; Female; Finland; Humans; Iceland; Male; Maxillary Sinusitis; Middle Aged; Single-Blind Method; Sweden; Treatment Outcome; United States	1992
Antibiotic therapy for urinary tract infections. The American journal of medicine, 1992, Jun-22, Volume: 92, Issue:6A Topics: Cefaclor; Cephalosporins; Clinical Trials as Topic; Europe; Female; Humans; Male; Norfloxacin; United States; Urinary Tract Infections	1992
Loracarbef. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy. Drugs, 1993, Volume: 45, Issue:5 Topics: Adolescent; Adult; Aged; Cephalosporins; Child; Humans; Microbial Sensitivity Tests; Middle Aged; Randomized Controlled Trials as Topic	1993
A critical review of the new oral cephalosporins. Considerations and place in therapy. Archives of family medicine, 1994, Volume: 3, Issue:11 Topics: Administration, Oral; Anti-Infective Agents; Cefixime; Cefotaxime; Cefpodoxime; Cefprozil; Ceftizoxime; Cephalosporins; Humans	1994
The role of newer oral cephalosporins, fluoroquinolones, and macrolides in the treatment of pediatric infections. Advances in pediatric infectious diseases, 1994, Volume: 9 Topics: Administration, Oral; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacterial Infections; Cefixime; Cefotaxime; Cefpodoxime Proxetil; Cefprozil; Ceftibuten; Ceftizoxime; Cefuroxime; Cephalosporins; Child; Clarithromycin; Fluoroquinolones; Humans	1994
Symposium on antimicrobial therapy. V. The carbapenems and monobactams. The Journal of the Oklahoma State Medical Association, 1993, Volume: 86, Issue:2 Topics: Aztreonam; Bacterial Infections; Cephalosporins; Humans; Imipenem; Microbial Sensitivity Tests	1993
Loracarbef: a new orally administered carbacephem antibiotic. The Annals of pharmacotherapy, 1993, Volume: 27, Issue:3 Topics: Administration, Oral; Bacterial Infections; Cephalosporins; Drug Interactions; Humans; Microbial Sensitivity Tests	1993
Pharmacokinetics of new oral cephalosporins, including a new carbacephem. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1993, Volume: 16, Issue:5 Topics: Administration, Oral; Aged; Biological Availability; Cephalosporins; Child; Drug Administration Schedule; Drug Interactions; Food; Humans; Infant	1993
Comparison of cefprozil, cefpodoxime proxetil, loracarbef, cefixime, and ceftibuten. The Annals of pharmacotherapy, 1996, Volume: 30, Issue:3 Topics: Bacterial Infections; Cefixime; Cefotaxime; Cefpodoxime Proxetil; Cefprozil; Ceftibuten; Ceftizoxime; Cephalosporins; Humans; Microbial Sensitivity Tests; Prodrugs; Randomized Controlled Trials as Topic	1996
A systematic review of randomised clinical trials for oral antibiotic treatment of acute pyelonephritis. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2018, Volume: 37, Issue:12 Topics: Acute Disease; Administration, Oral; Anti-Bacterial Agents; Cephalosporins; Ciprofloxacin; Drug Combinations; Humans; Norfloxacin; Pyelonephritis; Randomized Controlled Trials as Topic; Sulfamethizole; Trimethoprim	2018

Trials

25 trial(s) available for cephalosporin c and ly 163892

Article	Year
Pharmacokinetics of loracarbef and interaction with acetylcysteine. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1992, Volume: 11, Issue:9 Topics: Acetylcysteine; Administration, Oral; Adult; Cephalosporins; Drug Combinations; Drug Interactions; Eating; Fasting; Humans; Male	1992
Loracarbef (LY 163892) vs amoxicillin/clavulanate in bacterial maxillary sinusitis. Ear, nose, & throat journal, 1992, Volume: 71, Issue:5 Topics: Adolescent; Adult; Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Bacterial Infections; Cephalosporins; Clavulanic Acids; Decision Trees; Drug Therapy, Combination; Female; Humans; Male; Maxillary Sinusitis; Middle Aged; Severity of Illness Index	1992
Comparative United States and European trials of loracarbef in the treatment of acute otitis media. The Pediatric infectious disease journal, 1992, Volume: 11, Issue:8 Suppl Topics: Acute Disease; Amoxicillin; Cephalosporins; Clinical Trials as Topic; Europe; Humans; Otitis Media; United States	1992
Loracarbef (LY163892) vs. penicillin VK in the treatment of streptococcal pharyngitis and tonsillitis. The Pediatric infectious disease journal, 1992, Volume: 11, Issue:8 Suppl Topics: Cephalosporins; Child; Child, Preschool; Double-Blind Method; Female; Humans; Infant; Male; Penicillin V; Pharyngitis; Streptococcal Infections; Streptococcus pyogenes; Tonsillitis	1992
Loracarbef vs. cefaclor in pediatric skin and skin structure infections. The Pediatric infectious disease journal, 1992, Volume: 11, Issue:8 Suppl Topics: Cefaclor; Cephalosporins; Child; Child, Preschool; Double-Blind Method; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Male; Skin Diseases, Infectious; Staphylococcal Skin Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus pyogenes	1992
Loracarbef (LY163892) versus amoxicillin-clavulanate in the treatment of bacterial acute otitis media with effusion. The Journal of pediatrics, 1992, Volume: 120, Issue:6 Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Bacterial Infections; Cephalosporins; Clavulanic Acids; Double-Blind Method; Drug Evaluation; Drug Therapy, Combination; Female; Haemophilus influenzae; Humans; Infant; Male; Moraxella catarrhalis; Otitis Media with Effusion; Streptococcus pneumoniae	1992
Loracarbef (LY163892) in the treatment of acute exacerbations of chronic bronchitis: results of U.S. and European comparative clinical trials. The American journal of medicine, 1992, Jun-22, Volume: 92, Issue:6A Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Bronchitis; Cephalosporins; Chronic Disease; Clavulanic Acids; Diarrhea; Drug Therapy, Combination; Europe; Female; Headache; Humans; Incidence; Male; Middle Aged; Treatment Outcome; United States	1992
Acute bacterial maxillary sinusitis: results of U.S. and European comparative therapy trials. The American journal of medicine, 1992, Jun-22, Volume: 92, Issue:6A Topics: Adolescent; Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Cephalosporins; Clavulanic Acids; Double-Blind Method; Doxycycline; Drug Therapy, Combination; Female; Finland; Humans; Iceland; Male; Maxillary Sinusitis; Middle Aged; Single-Blind Method; Sweden; Treatment Outcome; United States	1992
Loracarbef versus penicillin VK in the treatment of streptococcal pharyngitis and tonsillitis in an adult population. The American journal of medicine, 1992, Jun-22, Volume: 92, Issue:6A Topics: Adult; Cephalosporins; Cough; Diarrhea; Double-Blind Method; Headache; Humans; North America; Penicillin V; Pharyngitis; Streptococcal Infections; Streptococcus pyogenes; Tonsillitis	1992
Loracarbef (LY163892) versus cefaclor in the treatment of bacterial skin and skin-structure infections in an adult population. The American journal of medicine, 1992, Jun-22, Volume: 92, Issue:6A Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Cefaclor; Cephalosporins; Child; Double-Blind Method; Gastrointestinal Diseases; Headache; Humans; Incidence; Middle Aged; Skin Diseases, Infectious; Treatment Outcome	1992
Loracarbef (LY163892) versus cefaclor and norfloxacin in the treatment of uncomplicated pyelonephritis. The American journal of medicine, 1992, Jun-22, Volume: 92, Issue:6A Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cefaclor; Cephalosporins; Diarrhea; Double-Blind Method; Europe; Female; Headache; Humans; Male; Middle Aged; Nausea; Norfloxacin; Pyelonephritis; Treatment Outcome; United States	1992
Bactericidal titers of loracarbef (LY 163892) in serum and killing rates in volunteers receiving 400 versus 200 milligrams. Antimicrobial agents and chemotherapy, 1992, Volume: 36, Issue:3 Topics: Administration, Oral; Adult; Cephalosporins; Dose-Response Relationship, Drug; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Random Allocation	1992
Comparative evaluation of loracarbef and amoxicillin-clavulanate for acute otitis media. Antimicrobial agents and chemotherapy, 1991, Volume: 35, Issue:5 Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Bacteria; Cephalosporins; Child, Preschool; Clavulanic Acids; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Infant; Male; Microbial Sensitivity Tests; Otitis Media; Random Allocation; Recurrence	1991
Loracarbef versus cefaclor in the treatment of urinary tract infections in women. Antimicrobial agents and chemotherapy, 1991, Volume: 35, Issue:4 Topics: Cefaclor; Cephalosporins; Double-Blind Method; Female; Humans; Urinary Tract Infections	1991
Pharmacokinetic disposition of loracarbef in healthy young men and women at steady state. Journal of clinical pharmacology, 1994, Volume: 34, Issue:9 Topics: Adult; Cephalosporins; Drug Administration Schedule; Female; Humans; Male; Metabolic Clearance Rate; Specimen Handling; Time Factors	1994
Antimicrobial drug suspensions: a blinded comparison of taste of twelve common pediatric drugs including cefixime, cefpodoxime, cefprozil and loracarbef. The Pediatric infectious disease journal, 1994, Volume: 13, Issue:2 Topics: Analysis of Variance; Anti-Bacterial Agents; Anti-Infective Agents; Cefixime; Cefotaxime; Cefpodoxime; Cefprozil; Ceftizoxime; Cephalosporins; Child; Child, Preschool; Drug Combinations; Humans; Infant; Single-Blind Method; Smell; Suspensions; Taste	1994
Loracarbef versus doxycycline in the treatment of acute bacterial maxillary sinusitis. Scandinavian Study Group. The Journal of antimicrobial chemotherapy, 1993, Volume: 31, Issue:6 Topics: Acute Disease; Bacteria; Cephalosporins; Double-Blind Method; Doxycycline; Humans; Maxillary Sinusitis; Microbial Sensitivity Tests	1993
Factors influencing outcome in children treated with antibiotics for acute otitis media. The Pediatric infectious disease journal, 1993, Volume: 12, Issue:1 Topics: Acute Disease; Amoxicillin; Anti-Bacterial Agents; Cefaclor; Cefixime; Cefotaxime; Cephalosporins; Child; Child, Preschool; Clinical Trials as Topic; Female; Follow-Up Studies; Humans; Infant; Male; Otitis Media; Regression Analysis; Risk Factors; Treatment Outcome	1993
A national collaborative study of the in vitro activity of oral cephalosporins and loracarbef (LY 163892). Australian Group for the Study of Antimicrobial Resistance (AGAR). Pathology, 1997, Volume: 29, Issue:1 Topics: Administration, Oral; Australia; Cephalosporins; Drug Resistance, Microbial; Enterobacteriaceae; Gram-Positive Bacteria; Laboratories, Hospital; Microbial Sensitivity Tests; Streptococcus pneumoniae	1997
Loracarbef versus phenoxymethylpenicillin in the treatment of recurrent streptococcal pharyngotonsillitis. Scandinavian journal of infectious diseases, 1997, Volume: 29, Issue:2 Topics: Cephalosporins; Double-Blind Method; Humans; Penicillin V; Penicillins; Pharyngeal Diseases; Streptococcal Infections; Tonsillitis	1997
Comparative bioavailability of loracarbef chewable tablet vs. oral suspension in children. The Pediatric infectious disease journal, 1998, Volume: 17, Issue:12 Topics: Administration, Oral; Analysis of Variance; Area Under Curve; Bacterial Infections; Biological Availability; Cephalosporins; Child; Child, Preschool; Female; Humans; Male; Suspensions; Tablets	1998
Loracarbef versus clarithromycin in children with acute otitis media with effusion. Clinical therapeutics, 1999, Volume: 21, Issue:4 Topics: Acute Disease; Anti-Bacterial Agents; Cephalosporins; Child, Preschool; Clarithromycin; Humans; Infant; Otitis Media with Effusion; Single-Blind Method; Treatment Outcome	1999
A comparison of a five-day regimen of cefdinir with a seven-day regimen of loracarbef for the treatment of acute exacerbations of chronic bronchitis. International journal of clinical practice, 2000, Volume: 54, Issue:5 Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Bacterial Infections; Bronchitis; Cefdinir; Cephalosporins; Chronic Disease; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Prospective Studies; Sputum; Treatment Outcome	2000
Penicillin V, loracarbef and clindamycin in tonsillar surface fluid during acute group A streptococcal pharyngotonsillitis. Scandinavian journal of infectious diseases, 2005, Volume: 37, Issue:6-7 Topics: Adult; Aged; Anti-Bacterial Agents; C-Reactive Protein; Cephalosporins; Clindamycin; Female; Humans; Male; Middle Aged; Orosomucoid; Palatine Tonsil; Penicillin V; Streptococcal Infections; Streptococcus pyogenes; Tissue Distribution; Tonsillitis	2005
Twice-daily dosing of loracarbef 15 mg/kg versus 30 mg/kg in the treatment of children with acute sinusitis. Drugs under experimental and clinical research, 2005, Volume: 31 Suppl Topics: Acute Disease; Anti-Bacterial Agents; Cephalosporins; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Sinusitis	2005

Other Studies

63 other study(ies) available for cephalosporin c and ly 163892

Article	Year
Advances in outpatient antimicrobial therapy: loracarbef. The American journal of medicine, 1992, Jun-22, Volume: 92, Issue:6A Topics: Ambulatory Care; Cephalosporins; Humans; Randomized Controlled Trials as Topic	1992
Antibiotic susceptibility of upper respiratory tract pathogens in Sweden: a seven year follow-up study including loracarbef. Swedish Respiratory Tract Study Group. Scandinavian journal of infectious diseases, 1992, Volume: 24, Issue:4 Topics: Cephalosporins; Drug Resistance, Microbial; Follow-Up Studies; Haemophilus influenzae; Humans; Moraxella catarrhalis; Respiratory Tract Infections; Streptococcus pneumoniae; Streptococcus pyogenes; Sweden	1992
In vitro susceptibility of Haemophilus influenzae to cefaclor, cefixime, cefetamet and loracarbef. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1992, Volume: 11, Issue:8 Topics: Ampicillin Resistance; Cefaclor; Cefixime; Cefotaxime; Ceftizoxime; Cephalosporins; Haemophilus influenzae; Microbial Sensitivity Tests; Regression Analysis	1992
Development of revised quality control limits for disk diffusion susceptibility tests of selected cephem antibiotics with Haemophilus influenzae and description of a new control strain. Journal of clinical microbiology, 1992, Volume: 30, Issue:8 Topics: Ampicillin; Cefaclor; Cefamandole; Cefonicid; Cefuroxime; Cephalosporins; Evaluation Studies as Topic; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Quality Control; Reference Standards	1992
Iron transport-mediated antibacterial activity of and development of resistance to hydroxamate and catechol siderophore-carbacephalosporin conjugates. Antimicrobial agents and chemotherapy, 1992, Volume: 36, Issue:4 Topics: Catechols; Cell Division; Cephalosporins; Drug Resistance, Microbial; Escherichia coli; Ferric Compounds; Hydroxamic Acids; Microbial Sensitivity Tests	1992
Loracarbef. The Medical letter on drugs and therapeutics, 1992, Sep-18, Volume: 34, Issue:879 Topics: Adult; Cephalosporins; Child; Clinical Trials as Topic; Costs and Cost Analysis; Humans; Microbial Sensitivity Tests; Respiratory Tract Infections; Skin Diseases, Infectious; Urinary Tract Infections	1992
Pharmaceutical properties of loracarbef: the remarkable solution stability of an oral 1-carba-1-dethiacephalosporin antibiotic. Pharmaceutical research, 1992, Volume: 9, Issue:2 Topics: Cefaclor; Cephalexin; Cephalosporins; Chromatography, High Pressure Liquid; Colorimetry; Crystallization; Drug Stability; Hydrogen-Ion Concentration; Isoelectric Focusing; Kinetics; Solubility; Solutions; Thermodynamics; X-Ray Diffraction	1992
New antibiotics for skin and skin structure infections. Orthopaedic review, 1992, Volume: 21, Issue:6 Topics: Cefprozil; Cephalosporins; Humans; Skin Diseases, Infectious	1992
Advances in outpatient antimicrobial therapy: loracarbef. June 12-15, 1991, San Francisco, California. Proceedings. The American journal of medicine, 1992, Jun-22, Volume: 92, Issue:6A Topics: Ambulatory Care; Cephalosporins; Humans	1992
Comparative in vitro activity of cefixime, cefaclor and loracarbef against urinary pathogens. Drugs under experimental and clinical research, 1991, Volume: 17, Issue:10-11 Topics: Anti-Infective Agents, Urinary; Bacteria; Cefaclor; Cefixime; Cefotaxime; Cephalosporins; Humans; Microbial Sensitivity Tests; Urinary Tract Infections	1991
Effect of loracarbef on the normal oropharyngeal and intestinal microflora. Scandinavian journal of infectious diseases, 1991, Volume: 23, Issue:2 Topics: Administration, Oral; Adult; Bacteria; Cephalosporins; Feces; Female; Humans; Intestines; Male; Oropharynx	1991
In-vitro activity of cefprozil (BMY 28100) and loracarbef (LY 163892) against pathogens obtained from middle ear fluid. The Journal of antimicrobial chemotherapy, 1991, Volume: 27, Issue:3 Topics: Acute Disease; Cefprozil; Cephalosporins; Ear, Middle; Haemophilus influenzae; Moraxella catarrhalis; Otitis Media; Streptococcus pneumoniae	1991
High-performance liquid chromatographic determination of loracarbef, a potential metabolite, cefaclor and cephalexin in human plasma, serum and urine. Journal of chromatography, 1991, Jun-14, Volume: 567, Issue:1 Topics: Cefaclor; Cephalexin; Cephalosporins; Chromatography, High Pressure Liquid; Humans; Molecular Structure; Spectrophotometry, Ultraviolet	1991
In vitro activity of loracarbef (LY163892), a new oral carbacephem antimicrobial agent, against respiratory isolates of Haemophilus influenzae and Moraxella catarrhalis. Antimicrobial agents and chemotherapy, 1991, Volume: 35, Issue:7 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactamases; Cephalosporins; Haemophilus Infections; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Moraxella catarrhalis; Respiratory Tract Infections	1991
Influence of subinhibitory concentrations of loracarbef (LY 163892) and daptomycin (LY 146032) on bacterial phagocytosis, killing and serum sensitivity. The Journal of antimicrobial chemotherapy, 1990, Volume: 26, Issue:4 Topics: Bacteria; Blood Bactericidal Activity; Cephalosporins; Daptomycin; Drug Resistance, Microbial; Humans; Immune Sera; Macrophages; Neutrophils; Peptides; Phagocytosis	1990
Loracarbef concentrations in middle ear fluid. Antimicrobial agents and chemotherapy, 1990, Volume: 34, Issue:10 Topics: Body Fluids; Cephalosporins; Child; Child, Preschool; Ear, Middle; Female; Humans; Infant; Male; Otitis Media; Tympanoplasty	1990
In vitro and in vivo antibacterial activity of KT3777, a new orally active carbacephem. The Journal of antibiotics, 1989, Volume: 42, Issue:12 Topics: Administration, Oral; Animals; Bacterial Infections; Cefaclor; Cephalexin; Cephalosporins; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Male; Mice; Microbial Sensitivity Tests	1989
Comparative in-vitro activity of a new oral carbacephem, LY163892. The Journal of antimicrobial chemotherapy, 1988, Volume: 22, Issue:4 Topics: Bacteria; Cephalosporins; Escherichia coli; Haemophilus influenzae; Microbial Sensitivity Tests; Penicillins; Staphylococcus aureus	1988
In vitro susceptibilities of common pediatric pathogens to LY163892. Antimicrobial agents and chemotherapy, 1988, Volume: 32, Issue:2 Topics: Anti-Bacterial Agents; Bacteria; Cephalosporins; Child; Escherichia coli; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Moraxella catarrhalis; Staphylococcus aureus; Streptococcus pneumoniae; Streptococcus pyogenes	1988
In vitro activity of LY163892 against pathogens isolated from pediatric patients. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1988, Volume: 7, Issue:3 Topics: Bacteria; Cephalosporins; Drug Resistance, Microbial; Haemophilus influenzae; Humans; Moraxella catarrhalis; Streptococcus pneumoniae	1988
In vitro activity and beta-lactamase stability of LY163892. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1988, Volume: 7, Issue:4 Topics: Administration, Oral; Bacteria; beta-Lactamases; Cefaclor; Cefotaxime; Cephalexin; Cephalosporins; Enzyme Stability	1988
Antimicrobial activity of LY163892, an orally administered 1-carbacephem. The Journal of antimicrobial chemotherapy, 1988, Volume: 22, Issue:3 Topics: Bacteria; Cefaclor; Cephalexin; Cephalosporins; Microbial Sensitivity Tests	1988
Influence of storage and susceptibility test conditions on stability and activity of LY163892 and four other cephalosporins. Antimicrobial agents and chemotherapy, 1988, Volume: 32, Issue:10 Topics: Bacteria; Cephalosporins; Culture Media; Drug Stability; Drug Storage; Humans; Hydrogen-Ion Concentration; Microbial Sensitivity Tests	1988
Pharmacokinetics of LY163892 in infants and children. Antimicrobial agents and chemotherapy, 1988, Volume: 32, Issue:11 Topics: Adolescent; Cephalosporins; Child; Child, Preschool; Female; Half-Life; Humans; Infant; Male; Metabolic Clearance Rate	1988
Disk diffusion susceptibility testing for LY163892 (KT-3777), a new orally administered 1-carbacephem. Journal of clinical microbiology, 1988, Volume: 26, Issue:4 Topics: Bacteria; Cefaclor; Cephalexin; Cephalosporins; Enterobacter; Haemophilus influenzae; Microbial Sensitivity Tests; Predictive Value of Tests; Providencia	1988
In-vitro activity and beta-lactamase stability of LY163892. The Journal of antimicrobial chemotherapy, 1988, Volume: 22, Issue:2 Topics: Amoxicillin; Bacteria; beta-Lactamases; Cell Wall; Cephalosporins; Clavulanic Acids; Enzyme Stability; Microbial Sensitivity Tests	1988
In vitro activities of LY163892, cefaclor, and cefuroxime. Antimicrobial agents and chemotherapy, 1988, Volume: 32, Issue:1 Topics: Anti-Bacterial Agents; Bacteria; Cefaclor; Cefuroxime; Cephalexin; Cephalosporins; Drug Stability; Temperature	1988
Beta-lactamase hydrolysis and inhibition studies of the new 1-carbacephem LY163892. European journal of clinical microbiology, 1987, Volume: 6, Issue:5 Topics: beta-Lactamase Inhibitors; beta-Lactamases; Cefaclor; Cefotaxime; Cephaloridine; Cephalosporins; Hydrolysis	1987
Formation of fluorescent pyrazine derivatives via a novel degradation pathway of the carbacephalosporin loracarbef. Journal of pharmaceutical and biomedical analysis, 1995, Volume: 13, Issue:3 Topics: Cephalosporins; Chromatography, High Pressure Liquid; Magnetic Resonance Spectroscopy; Pyrazines; Spectrometry, Fluorescence; Spectrometry, Mass, Fast Atom Bombardment; Spectrophotometry, Ultraviolet	1995
Mechanism and kinetics of transcellular transport of a new beta-lactam antibiotic loracarbef across an intestinal epithelial membrane model system (Caco-2). Pharmaceutical research, 1994, Volume: 11, Issue:10 Topics: Amino Acid Sequence; Biological Transport; Cells, Cultured; Cephalosporins; Culture Media; Dipeptides; Epithelial Cells; Epithelium; Humans; Hydrogen-Ion Concentration; Intestinal Absorption; Intestinal Mucosa; Mannitol; Models, Biological; Molecular Sequence Data	1994
Revised disk diffusion interpretive criteria for cefaclor, loracarbef, cefprozil and cefixime when testing Haemophilus influenzae on haemophilus test medium. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1994, Volume: 13, Issue:6 Topics: Cefaclor; Cefixime; Cefotaxime; Cefprozil; Cephalosporins; Culture Media; Haemophilus Infections; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Quality Control	1994
FDA announces recall of liquid antibiotics. Pennsylvania medicine, 1994, Volume: 97, Issue:5 Topics: Cefaclor; Cephalexin; Cephalosporins; Drug and Narcotic Control; United States; United States Food and Drug Administration	1994
Effect of loracarbef and amoxicillin on the oropharyngeal and intestinal microflora of patients with bronchitis. Scandinavian journal of infectious diseases, 1994, Volume: 26, Issue:2 Topics: Acute Disease; Adolescent; Adult; Amoxicillin; Bacteria, Anaerobic; Bronchitis; Cephalosporins; Enterococcus faecalis; Female; Gram-Negative Aerobic Bacteria; Humans; Intestines; Male; Microbial Sensitivity Tests; Oropharynx; Yeasts	1994
The pharmacokinetics, tissue penetration and in-vitro activity of loracarbef, a beta-lactam antibiotic of the carbacephem class. The Journal of antimicrobial chemotherapy, 1993, Volume: 32, Issue:6 Topics: Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Cefaclor; Cephalosporins; Clavulanic Acids; Drug Therapy, Combination; Enterobacteriaceae; Exudates and Transudates; Haemophilus influenzae; Half-Life; Humans; Male; Microbial Sensitivity Tests; Moraxella catarrhalis; Staphylococcus aureus; Streptococcus pneumoniae	1993
Predictive accuracy of disk diffusion test for Proteus vulgaris and Providencia species against five newer orally administered cephalosporins, cefdinir, cefetamet, cefprozil, cefuroxime, and loracarbef. Journal of clinical microbiology, 1994, Volume: 32, Issue:2 Topics: Administration, Oral; Cefdinir; Cefprozil; Ceftizoxime; Cefuroxime; Cephalosporins; Drug Resistance, Microbial; Evaluation Studies as Topic; False Positive Reactions; Humans; Microbial Sensitivity Tests; Proteus vulgaris; Providencia	1994
Transport mechanisms responsible for the absorption of loracarbef, cefixime, and cefuroxime axetil into human intestinal Caco-2 cells. Biochimica et biophysica acta, 1994, Apr-20, Volume: 1191, Issue:1 Topics: Adenocarcinoma; Amino Acids; Biological Transport; Cefixime; Cefotaxime; Cefuroxime; Cephalosporins; Colonic Neoplasms; Dipeptides; Drug Antagonism; Energy Metabolism; Humans; Intestinal Absorption; Tumor Cells, Cultured	1994
Sputum and serum pharmacokinetics of loracarbef (LY163892) in patients with chronic bronchial sepsis. The Journal of antimicrobial chemotherapy, 1994, Volume: 33, Issue:1 Topics: Adult; Aged; Albumins; Anti-Bacterial Agents; beta-Lactamases; Bronchiectasis; Cephalosporins; Chronic Disease; Female; Humans; Lung; Male; Middle Aged; Serum Albumin; Sputum	1994
Aqueous acidic degradation of the carbacephalosporin loracarbef. Journal of pharmaceutical sciences, 1993, Volume: 82, Issue:10 Topics: Cefaclor; Cephalosporins; Chromatography, High Pressure Liquid; Drug Stability; Hydrogen-Ion Concentration; Magnetic Resonance Spectroscopy; Mass Spectrometry; Molecular Structure; Solutions	1993
Haemophilus influenzae infection of human respiratory mucosa in low concentrations of antibiotics. The American review of respiratory disease, 1993, Volume: 148, Issue:1 Topics: Adenoids; Amoxicillin; Anti-Bacterial Agents; Cephalosporins; Child, Preschool; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Haemophilus Infections; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Microscopy, Electron; Mucociliary Clearance; Mucous Membrane; Organ Culture Techniques; Respiratory Tract Infections	1993
Effects of renal dysfunction on the pharmacokinetics of loracarbef. Clinical pharmacology and therapeutics, 1993, Volume: 54, Issue:3 Topics: Adult; Cephalosporins; Female; Humans; Kidney Failure, Chronic; Kidney Function Tests; Male; Middle Aged; Renal Dialysis	1993
New antibacterial agents. American pharmacy, 1993, Volume: NS33, Issue:1 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Fluoroquinolones; Humans; Macrolides	1993
General pharmacology of loracarbef in animals. Arzneimittel-Forschung, 1993, Volume: 43, Issue:1 Topics: Anesthetics, Local; Animals; Anti-Bacterial Agents; Blood Coagulation; Blood Glucose; Central Nervous System; Cephalosporins; Digestive System; Dogs; Guinea Pigs; Hemodynamics; Hemolysis; Immune System; Inflammation; Irritants; Kidney; Male; Mice; Platelet Aggregation; Rabbits; Rats; Rats, Inbred F344; Rats, Sprague-Dawley; Rats, Wistar	1993
In vitro effect on group A streptococci of loracarbef versus cefadroxil, cefaclor and penicillin V. Scandinavian journal of infectious diseases, 1993, Volume: 25, Issue:1 Topics: Anti-Bacterial Agents; Cefaclor; Cefadroxil; Cephalosporins; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Penicillin V; Pharyngitis; Streptococcal Infections; Streptococcus pyogenes	1993
Sputum and serum pharmacokinetics of loracarbef (LY163892) in patients with bronchial sepsis. The Journal of antimicrobial chemotherapy, 1995, Volume: 36, Issue:2 Topics: beta-Lactamases; Bronchial Diseases; Cephalosporins; Humans; Sepsis; Sputum	1995
Acute interstitial nephritis associated with loracarbef therapy. The Journal of pediatrics, 1995, Volume: 127, Issue:6 Topics: Acute Disease; Anti-Bacterial Agents; Biopsy; Cephalosporins; Humans; Infant; Kidney; Male; Necrosis; Nephritis, Interstitial; Otitis Media	1995
Cephalosporin and carbacephem nephrotoxicity. Roles of tubular cell uptake and acylating potential. Biochemical pharmacology, 1996, Feb-23, Volume: 51, Issue:4 Topics: Acylation; Ampicillin; Animals; Anti-Bacterial Agents; Biological Transport; Cephaloglycin; Cephalosporins; Half-Life; Infusions, Intravenous; Kidney; Kidney Cortex; Penicillins; Rabbits; Structure-Activity Relationship; Tissue Distribution	1996
Stereoselective uptake of beta-lactam antibiotics by the intestinal peptide transporter. British journal of pharmacology, 1995, Volume: 116, Issue:7 Topics: Animals; Anti-Bacterial Agents; Cadherins; Carrier Proteins; Cell Line; Cephalexin; Cephalosporins; Hydrolysis; Intestinal Mucosa; Membrane Transport Proteins; Microinjections; Oocytes; Peptides; Stereoisomerism; Xenopus laevis	1995
Bactericidal activities of cefprozil, penicillin, cefaclor, cefixime, and loracarbef against penicillin-susceptible and -resistant Streptococcus pneumoniae in an in vitro pharmacodynamic infection model. Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:5 Topics: Cefaclor; Cefixime; Cefotaxime; Cefprozil; Cephalosporins; Colony-Forming Units Assay; Humans; Microbial Sensitivity Tests; Models, Theoretical; Penicillin Resistance; Penicillins; Streptococcus pneumoniae	1996
Uptake characteristics of loracarbef and cephalexin in the Caco-2 cell culture model: effects of the proton gradient and possible presence of a distinctive second component. Journal of pharmaceutical sciences, 1996, Volume: 85, Issue:7 Topics: Caco-2 Cells; Cephalexin; Cephalosporins; Humans; Peptides; Protons	1996
Peptide transporter function and prolidase activities in Caco-2 cells: a lack of coordinated expression. Journal of drug targeting, 1995, Volume: 3, Issue:4 Topics: Basement Membrane; Biological Transport; Caco-2 Cells; Cell Division; Cephalosporins; Dipeptidases; Dipeptides; Humans; Kinetics; Peptides; Protons	1995
Recurrence of pneumococcal sepsis caused by an intermediately penicillin-resistant organism treated with loracarbef. The Pediatric infectious disease journal, 1996, Volume: 15, Issue:4 Topics: Bacteremia; Cephalosporins; Drug Resistance, Microbial; Humans; Infant; Male; Pneumococcal Infections; Recurrence	1996
Acute liver injury due to loracarbef. Journal of hepatology, 1997, Volume: 26, Issue:3 Topics: Acute Disease; Aged; Biopsy; Cephalosporins; Chemical and Drug Induced Liver Injury; Cholestasis, Extrahepatic; Follow-Up Studies; Humans; Liver Diseases; Male	1997
Structure-activity relationship of carbacephalosporins and cephalosporins: antibacterial activity and interaction with the intestinal proton-dependent dipeptide transport carrier of Caco-2 cells. Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:8 Topics: Caco-2 Cells; Cadherins; Carrier Proteins; Cephalexin; Cephalosporins; Humans; Lactams; Membrane Transport Proteins; Microbial Sensitivity Tests; Stereoisomerism; Structure-Activity Relationship	1997
Cefaclor: a contemporary look at susceptibility of key pathogens from around the globe. Journal of chemotherapy (Florence, Italy), 1998, Volume: 10, Issue:3 Topics: Anti-Infective Agents; Cefaclor; Cephalosporins; Ciprofloxacin; Escherichia coli; Haemophilus influenzae; Methicillin Resistance; Microbial Sensitivity Tests; Moraxella catarrhalis; Penicillin Resistance; Staphylococcus aureus	1998
The effects of the morphological response of Enterobacteriaceae to cephalosporins on PAE and CERT. Scandinavian journal of infectious diseases, 1998, Volume: 30, Issue:4 Topics: Cefaclor; Cefuroxime; Cephalosporins; Colony Count, Microbial; Culture Media; Electric Impedance; Enterobacteriaceae; Luminescent Measurements; Microbial Sensitivity Tests	1998
Determination of the antimicrobial susceptibilities of Canadian isolates of Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis. Canadian Antimicrobial Study Group. The Journal of antimicrobial chemotherapy, 1999, Volume: 43 Suppl A Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Ciprofloxacin; Haemophilus influenzae; Microbial Sensitivity Tests; Moraxella catarrhalis; Penicillin Resistance; Respiratory Tract Infections; Streptococcus pneumoniae	1999
Assessment of the susceptibility of Streptococcus pneumoniae to cefaclor and loracarbef in 13 countries. Journal of chemotherapy (Florence, Italy), 2000, Volume: 12, Issue:4 Topics: Cefaclor; Cephalosporins; Europe; Humans; Microbial Sensitivity Tests; North America; Penicillin Resistance; Russia; Streptococcus pneumoniae	2000
Effect of step-down therapy of ceftriaxone plus loracarbef versus parenteral therapy of ceftriaxone on the intestinal microflora in patients with community-acquired pneumonia. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2001, Volume: 7, Issue:7 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Drug Therapy, Combination; Feces; Female; Hospitalization; Humans; Infusions, Intravenous; Intestines; Male; Middle Aged; Pneumonia; Treatment Outcome	2001
In-vitro susceptibility of Haemophilus influenzae to loracarbef (LY 163892) and other oral antibiotics. Collaborative Study Group on Pediatric Infectious Disease in Lombardy. Journal of chemotherapy (Florence, Italy), 1991, Volume: 3 Suppl 1 Topics: Adult; Ampicillin; Anti-Bacterial Agents; Cephalosporins; Child; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Erythromycin; Haemophilus Infections; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Penicillins	1991
Serologically documented loracarbef (Lorabid)-induced immune thrombocytopenia. American journal of hematology, 2003, Volume: 73, Issue:1 Topics: Autoantibodies; Blood Platelets; Cephalosporins; Female; Flow Cytometry; Humans; Methylprednisolone; Middle Aged; Purpura, Thrombocytopenic, Idiopathic; Respiratory Tract Infections	2003
In vitro evaluation of Ly 163892, a new oral cephalosporin. Journal of chemotherapy (Florence, Italy), 1989, Volume: 1, Issue:4 Suppl Topics: Anti-Bacterial Agents; Bacteria; Cefaclor; Cephalosporins; Microbial Sensitivity Tests	1989
Differentiation of cefaclor and its delta-3 isomer by electrospray mass spectrometry, infrared multiple photon dissociation spectroscopy and theoretical calculations. Journal of mass spectrometry : JMS, 2015, Volume: 50, Issue:1 Topics: Cefaclor; Cephalosporins; Isomerism; Quantum Theory; Spectrometry, Mass, Electrospray Ionization; Spectrophotometry, Infrared; Tandem Mass Spectrometry	2015
Kinetic Study of Laboratory Mutants of NDM-1 Metallo-β-Lactamase and the Importance of an Isoleucine at Position 35. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:4 Topics: Amino Acid Substitution; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Biocatalysis; Catalytic Domain; Cephalosporins; Cloning, Molecular; Escherichia coli; Gene Expression; Isoleucine; Kinetics; Models, Molecular; Mutation; Protein Structure, Secondary; Recombinant Proteins; Serine; Threonine	2016